Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control

BACKGROUND AND AIM: Management of genotype 4 hepatitis C virus (HCV) has shifted to interferon‐free regimens with a high sustained virological response (SVR‐12), especially with NS5B/NS5A inhibitor combinations such as sofosbuvir and ledipasvir (Sof‐Led). The guidelines have recommended the combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Joharji, Hala, Alkortas, Delal, Ajlan, Aziza, Ahmed, Mohamed, Al‐Ashgar, Hamad, Al‐Quaiz, Mohammed, Broering, Dieter, Al‐Sebayel, Mohammed, Elsiesy, Hussien, Alkhail, Faisal A., Al‐Hamoudi, Waleed K., De Vol, Edward, Amirah Almuhayshir, Epi, Al‐Jedai, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731361/
https://www.ncbi.nlm.nih.gov/pubmed/36514327
http://dx.doi.org/10.1002/hsr2.980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731361/
https://www.ncbi.nlm.nih.gov/pubmed/36514327
http://dx.doi.org/10.1002/hsr2.980

Ejemplares similares